All Stories

  1. Myometrial Microbiome in Uterine Fibroids: Functional Dysbiosis Versus Limited Taxonomic Change
  2. Revisiting the role of danazol in the contemporary management of endometriosis-related pain: a systematic review
  3. Multidimensional factors increase menstrual distress in patients with endometriosis
  4. Expression of cannabinoid receptors CB1, CB2 and GPR18 in adenomyotic lesions
  5. Human Leukocyte Antigen Haplotypes Predisposing to Celiac Disease in Patients With Endometriosis
  6. Diet characteristics in patients with endometriosis
  7. Iron Deficiency Anemia and Uterine Disorders: Impact on Surgical Management
  8. Endometriotic lesions express microRNAs that potentially regulate the transcription of hydroxysteroid 17-beta dehydrogenase 2 (HSD17B2): a pilot study
  9. Iron deficiency anemia: preconceptional, pregnancy and postpartum management – a call for action
  10. Abnormal uterine bleeding: The well-known and the hidden face
  11. The modern management of uterine fibroids-related abnormal uterine bleeding
  12. Imaging and molecular features of adenomyosis after menopause
  13. An update for endometriosis management: a position statement
  14. Endometriosis and sexual disorders: the effect of surgical and medical treatment, a multicentre cross-sectional study
  15. A 10-Year Observational Study on Twin Pregnancy: Role of Fetal Sex Pairing on Obstetric Outcome
  16. Sphingosine 1‐phosphate elicits a ROS‐mediated proinflammatory response in human endometrial stromal cells via ERK5 activation
  17. Uterine Fibroids, Perceived Stress, and Menstrual Distress: a Key Role of Heavy Menstrual Bleeding
  18. Adenomyosis: is an endocrine-related uterine dysfunction?
  19. Advances in targeting estrogen synthesis and receptors in patients with endometriosis
  20. Sphingosine 1-phosphate pathway is dysregulated in adenomyosis
  21. Perinatal outcomes of pregnant women with severe COVID-19 requiring extracorporeal membrane oxygenation (ECMO): a case series and literature review
  22. Long-term treatment of endometriosis-related pain among women seeking hormonal contraception
  23. Menstruation-Related Disorders—Dysmenorrhea and Heavy Bleeding—as Significant Epiphenomena in Women With Rheumatic Diseases
  24. Undifferentiated Connective Tissue Disease in Pregnancy: A Topic Yet to be Explored
  25. The global pandemic and changes in women’s reproductive health: an observational study
  26. Insights on Adenomyosis Development
  27. Menstrual Distress Questionnaire (MEDI-Q): a new tool to assess menstruation-related distress
  28. Maternal hemodynamic changes in gestational diabetes: a prospective case–control study
  29. Hormonal treatments for endometriosis: The endocrine background
  30. What is the role of glycemic control in the development of preeclampsia among women with type 1 diabetes?
  31. Sphingosine 1-phosphate signaling in uterine fibroids: implication in activin A pro-fibrotic effect
  32. Comorbidities and Quality of Life in Women Undergoing First Surgery for Endometriosis: Differences Between Chinese and Italian Population
  33. Different Gestational Diabetes Phenotypes: Which Insulin Regimen Fits Better?
  34. Fetal nondiabetic-macrosomia: risk factors for pregnancy adverse outcome and comparison of two growth curves in the prediction of cesarean section
  35. Is primary dysmenorrhea a precursor of future endometriosis development?
  36. Long-term hormonal treatment reduces repetitive surgery for endometriosis recurrence
  37. Fetal Growth Restriction: Does an Integrated Maternal Hemodynamic-Placental Model Fit Better?
  38. Immunological changes associated with adenomyosis: a systematic review
  39. Emergency surgery for appendectomy and incidental diagnosis of superficial peritoneal endometriosis in fertile age women
  40. Progesterone receptor ligands for the treatment of endometriosis: the mechanisms behind therapeutic success and failure
  41. Adenomyosis: Mechanisms and Pathogenesis
  42. Ultrasound findings in infertile women with endometriosis: evidence of concomitant uterine disorders
  43. Diagnosing adenomyosis: an integrated clinical and imaging approach
  44. Dysmenorrhea and Heavy Menstrual Bleeding in Elite Female Athletes: Quality of Life and Perceived Stress
  45. Is Stress a Cause or a Consequence of Endometriosis?
  46. Influence of assisted reproductive technologies on maternal and neonatal outcomes in early preterm deliveries
  47. Surgical treatment of endometriosis: prognostic factors for better quality of life
  48. Recent advances in understanding and managing adenomyosis
  49. Using fetal abdominal circumference growth velocity in the prediction of adverse outcome in near‐term small‐for‐gestational‐age fetuses
  50. Is pulsating cord blood sampling a suitable and reliable method for cord gas analysis at birth?
  51. Human leukocyte antigen DQ2/DQ8 positivity in women with history of stillbirth
  52. An objective scoring method to evaluate image quality of middle cerebral artery Doppler
  53. Women’s attitude toward gynecological pain in fertile age: Results from a cross-sectional study among Italian community pharmacies
  54. Role of medical therapy in the management of uterine adenomyosis
  55. The influence of fetal sex on the antenatal diagnosis of small for gestational age
  56. Pathogenesis of adenomyosis: an update on molecular mechanisms
  57. Mental health, pain symptoms and systemic comorbidities in women with endometriosis: a cross-sectional study
  58. A reference range of fetal abdominal circumference growth velocity between 20 and 36 weeks' gestation
  59. Fetal middle cerebral artery Doppler in late-term pregnancy: a predicting factor for failed induction of labor
  60. Placental and maternal serum activin A in spontaneous and induced labor in late-term pregnancy
  61. Is fetal analgesia necessary during prenatal surgery?
  62. Deep Infiltrating Endometriosis and Endometrial Adenocarcinoma Express High Levels of Myostatin and Its Receptors Messenger RNAs
  63. Long-Term Vaginal Danazol Treatment in Fertile Age Women with Adenomyosis
  64. Twin pregnancies after assisted reproductive technologies: the role of maternal age on pregnancy outcome
  65. Endocrinology of human parturition
  66. Potential influence of in utero and early neonatal exposures on the later development of endometriosis
  67. CD93 and dystroglycan cooperation in human endothelial cell adhesion and migration
  68. AISF position paper on liver disease and pregnancy
  69. Current and future medical treatment of adenomyosis
  70. Infertility and reproductive disorders: impact of hormonal and inflammatory mechanisms on pregnancy outcome
  71. Placenta expresses anti-Müllerian hormone and its receptor: Sex-related difference in fetal membranes
  72. Term histologic chorioamnionitis: a heterogeneous condition
  73. The Influence of Doctor-Patient and Midwife-Patient Relationship in Quality Care Perception of Italian Pregnant Women: An Exploratory Study
  74. Anterior placental location influences onset and progress of labor and postpartum outcome
  75. Surgical treatment affects perceived stress differently in women with endometriosis: correlation with severity of pain
  76. Endometriosis and Perceived Stress: Impact of Surgical and Medical Treatment
  77. PCOS and Pregnancy: Impact of Endocrine and Metabolic Factors
  78. Women with endometriosis at first pregnancy have an increased risk of adverse obstetric outcome